KRAS and neoplasm: In this manuscript, we performed a relatively large-scale study to determine the correlation between the percentage of tumor cellularity estimated by certified anatomic pathologists and VAFs of well-studied driver mutations detected in key oncogenes (i.e., BRAF, EGFR, KRAS, and NRAS).